9 Meters Biopharma, Inc. (NMTR)

9 Meters Biopharma (NMTR) Stock Price & Analysis


NMTR Stock Chart & Stats

Day’s Range$0.07 - $0.1127
52-Week Range― - ―
Previous Close$0.13
Average Volume (3M)N/A
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
Shares Outstanding14,459,690
10 Day Avg. Volume2,832,758
30 Day Avg. Volume970,565
Standard Deviation0.26
Financial Highlights & Ratios
Price to Book (P/B)-0.13
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside938.78% Upside
Rating ConsensusHold
Number of Analyst Covering3



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was 9 Meters Biopharma, Inc.’s price range in the past 12 months?
Currently, no data Available
What is 9 Meters Biopharma, Inc.’s market cap?
Currently, no data Available
When is 9 Meters Biopharma, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were 9 Meters Biopharma, Inc.’s earnings last quarter?
Currently, no data Available
Is 9 Meters Biopharma, Inc. overvalued?
According to Wall Street analysts 9 Meters Biopharma, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
    Does 9 Meters Biopharma, Inc. pay dividends?
    9 Meters Biopharma, Inc. does not currently pay dividends.
    What is 9 Meters Biopharma, Inc.’s EPS estimate?
    9 Meters Biopharma, Inc.’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does 9 Meters Biopharma, Inc. have?
    Currently, no data Available
    What happened to 9 Meters Biopharma, Inc.’s price movement after its last earnings report?
    Currently, no data Available
    Which hedge fund is a major shareholder of 9 Meters Biopharma, Inc.?
    Currently, no hedge funds are holding shares in NMTR


    9 Meters Biopharma Stock Smart Score

    This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
    Learn more about TipRanks Smart Score

    Company Description

    9 Meters Biopharma, Inc.

    Innovate Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It foucs on developing novel medicines for autoimmune inflammatory disease. The company is founded by Jay P. Madan and Kendyle Woodard in 2012 and is headquartered in Raleigh, NC.


    Forecast EPS vs Actual EPS

    Currently, no data available
    Please return soon. This page is being updated.

    Similar Stocks
    Price & Change
    Bioxcel Therapeutics
    Frequency Therapeutics

    Popular Stocks

    What's Included in PREMIUM?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis